Drugs inflammatory and related disorder_ drugs used in Rx of Asthma Flashcards

(41 cards)

1
Q

_____ is an inflammatory disease associated with bronchial hyperactivity (BHR), bronchospasm, increase mucous secretion, edema, and cellular infiltration

A

Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

___________ is lasting from 30-60 minutes, are associated with bronchospasm from the actions of released histamine and LTs

A

Early asthmatic response (EAR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

________ involve infiltration of eosinophils and lymphocytes into airways —-> bronchoconstriction and inflammation with mucous plugging

A

Late asthmatic response (LAR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Management of asthma includes:

A

bronchodilators to provide short-term relief and anti-infalmmatroy agents that reduce bronchial hyperactivity and protect against cellular infiltration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

______ that inhibits acetylcholine

A

Ipratropium (relaxes bronchial smooth muscle)

Muscarnic receptor: vagal stimulation —->Ach =>bronchoconstriction which is blocked by muscarnic antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ipratropium and tiotropium are

A

muscarnic-receptor blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

_________ are choice in bronchospasm caused by beta-blockers

A

ipratropium ; tiotropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

there are minor atropine-like effect in

A

ipratropium; tiotropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ipratropium and tiotropium are used via __________ which causes _________?

A

inhalation; bronchodilation in acute asthma, esp. COPD patients and may be safer than B-agonist in patients with cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

safer than B-agonist in patients with cardiovascular disease

A

ipratropium; tiotropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Beta-receptors agonist also used in

A

Asthma patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which beta-agonists drugs are widely used in Rx of acute bronchoconstriction and prophylaxis of exercise-induced asthma

A

Beta-2 selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

beta-2 selective drugs are

A

albuterol (short acting); metaproterenol; terbutaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

longer acting beta-2 selective agonist

A

salmeterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

_________ may decrease nighttime attacks (propylaxis only) and permit dosage reduction of other agents

A

Salmeterol; formerterol

***not used as monotherapy, always give with corticosteriods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is a long acting muscarnic blocker

A

tiotropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

side effects of long acting beta-receptor agonists

A

HTN; arryhthymia; tremors

18
Q

aerosolic forms of asthma have ________ potential for systemic toxicity but may cause anxiety, muscle tremors and cardiovascular toxicity with overdose

A

Low (Beta-receptors agonist)

19
Q

_______ bronchodilates via inhibition of phosphodiesterase (PDE) —> increase cAMP due to decrease cAMP hydrolysis and also by antagonism of adenosine (bronchoconstrictor)

20
Q

antagonism of adenosine causes

A

bronchoconstriction

21
Q

methylxanthines are

22
Q

usage of _______ is limited b/c of its narrow therapeutic index (cardiotoxicity and neurotoxicity)

23
Q

Mainly adunctive; regular use may decrease symptoms but narrow therapeutic window

24
Q

Many drug interactions; toxicity increases by erythromycin, cimetidine, and fluroquinolones

25
___________ sometimes used in bronchospasm and status asthmaticus
aminophylline IV
26
Cromolyn and Nedocromil
prevents degranulation of pulmonary mast cells and decrease release of histamine, PAF and LTC4 from inflammatory cells
27
prevents degranulation of pulmonary mast cells and decrease release of histamine, PAF and LTC4 from inflammatory cells
Cromolyn (inhaler. nebulizer); Nedocromil
28
prophylactic use of Cromolyn and Nedocromil
decrease symptoms and bronchial hyperactivity (BHR), esp. responses to allergens
29
has minimal systemic toxicity but may cause throat irritation and cough
Cromolyn and Nedocromil
30
Relieved by beta-2 agonists
Cromolyn and Nedocromil
31
__________ block mediator release and decrease BHR via decrease expression PGS, LTs and inflammatory ILs, TNF-gamma/alpha/Gm-CSF resulting in increase immunosuppression
Glucocorticoids
32
__________ are a surface-active drugs used via inhalation for both acute attacks and for prophylaxis
Budesonide; Flunisolide | ***are glucocorticoid groups
33
_______ can cause oropharyngeal candidiasis which can be prevented via spacers and gargling
glucocorticoids
34
_______ low dose may prevent desensitization of beta-receptors that can occur with overuse of beta-2 agonist
Glucocorticoids
35
__________ (oral) and IV __________ generally reserved for severe acute attacks
Prednisone; Steroids (methylprednisone aka: solumedrol)
36
All asthmatic need a ________________ for acute attacks ; for Prophylaxis _____________ are most often used
short-acting beta-2 agonist; Glucocorticoids
37
For COPD (emphysema, chronic bronchitis), multiple ____________ are used including ___________ and ______ blockers
Bronchodilators; beta-2 agonists; M
38
_____________ and ____________ are antagonists at LTD4 receptors with slow onset of action used prophylactically for many forms of asthma, including antigen, exercise or drug-induced (ASA)
Zafirlukast; Monetlukast
39
__________ is selective inhibitor of lipoxygenases (LOX), decrease formation of all LTs from arachdonic acid
Zileuton
40
__________ has more rapid onset (1-3 hrs) and is adjunctive to steroids
Zileuton
41
side effects of Zileuton
Hepatotoxicity